Mohammad Bilal Malik, MD Internal Medicine - Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 313 N Alabama St Ste 1, Crossett, AR 71635 Phone: 501-906-3000 |
News Archive
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer.
Serving breakfast in the classroom instead of in the cafeteria is among the best options to overcome challenges such as time constraints and staffing issues when offering School Breakfast. According to the Food Research and Action Center's School Breakfast Scorecard for 2008-2009, districts using breakfast in the classroom have the highest participation rates.
NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services, announced today that it has validated and launched a series of NeoTYPE cancer profiling tests covering 22 different categories of cancer. Each of these tests is designed to investigate the most common and actionable genomic abnormalities reported for that particular tumor.
Handa Pharmaceuticals, LLC, a specialty pharmaceutical company based in Fremont, California, today confirmed that its Abbreviated New Drug Application ("ANDA") for Dexlansoprazole Delayed Release Capsules, 60 mg, a generic version of Takeda's DEXILANT®, has been accepted for review by the U.S. Food and Drug Administration.
› Verified 5 days ago